全文获取类型
收费全文 | 1740篇 |
免费 | 158篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 75篇 |
妇产科学 | 28篇 |
基础医学 | 305篇 |
口腔科学 | 35篇 |
临床医学 | 136篇 |
内科学 | 363篇 |
皮肤病学 | 5篇 |
神经病学 | 113篇 |
特种医学 | 43篇 |
外科学 | 292篇 |
综合类 | 17篇 |
预防医学 | 116篇 |
眼科学 | 24篇 |
药学 | 71篇 |
肿瘤学 | 256篇 |
出版年
2021年 | 9篇 |
2020年 | 22篇 |
2019年 | 18篇 |
2018年 | 27篇 |
2017年 | 22篇 |
2016年 | 41篇 |
2015年 | 22篇 |
2014年 | 33篇 |
2013年 | 56篇 |
2012年 | 59篇 |
2011年 | 79篇 |
2010年 | 47篇 |
2009年 | 39篇 |
2008年 | 64篇 |
2007年 | 59篇 |
2006年 | 86篇 |
2005年 | 84篇 |
2004年 | 74篇 |
2003年 | 41篇 |
2002年 | 72篇 |
2001年 | 75篇 |
2000年 | 52篇 |
1999年 | 48篇 |
1998年 | 41篇 |
1997年 | 22篇 |
1996年 | 27篇 |
1995年 | 30篇 |
1994年 | 18篇 |
1993年 | 15篇 |
1992年 | 57篇 |
1991年 | 46篇 |
1990年 | 37篇 |
1989年 | 40篇 |
1988年 | 37篇 |
1987年 | 30篇 |
1986年 | 46篇 |
1985年 | 47篇 |
1984年 | 41篇 |
1983年 | 28篇 |
1982年 | 18篇 |
1980年 | 12篇 |
1979年 | 22篇 |
1978年 | 13篇 |
1977年 | 16篇 |
1975年 | 14篇 |
1974年 | 14篇 |
1973年 | 12篇 |
1972年 | 13篇 |
1971年 | 11篇 |
1968年 | 9篇 |
排序方式: 共有1899条查询结果,搜索用时 15 毫秒
21.
Plewako H Arvidsson M Petruson K Oancea I Holmberg K Adelroth E Gustafsson H Sandström T Rak S 《The Journal of allergy and clinical immunology》2002,110(1):68-71
BACKGROUND: In sensitized patients, coupling between IgE and FcepsilonRI receptors on mast cells leads to release of proinflammatory mediators and a subsequent influx of inflammatory cells to the affected organ. Omalizumab (Xolair; formerly rhuMAb-E25) binds to circulating IgE, thus preventing induction of the allergic process. OBJECTIVE: We investigated the effect of treatment with omalizumab on seasonal allergic rhinitis and related changes in inflammatory cell numbers in nasal biopsy specimens. METHODS: Patients were randomized to treatment with omalizumab or placebo before the pollen season; the treatment was started and continued during season. Symptoms and use of medication were recorded, and blood samples and nasal biopsy specimens were obtained before and during season. Immunocytochemistry was performed on biopsy sections through use of the following antibodies: anti-CD4, CD8 (T lymphocytes), EG2, and anti-eosinophil peroxidase (eosinophils), anti-tryptase (mast cells), human neutrophil lipocalin (neutrophils), and antibodies against IgE and FcepsilonRI. RESULTS: During the season, blood eosinophils increased in placebo-treated patients but not in omalizumab-treated patients (P =.01); the difference between the treatment groups was significant (P =.04). Free IgE in serum decreased significantly (P =.0002) in omalizumab-treated patients but not in placebo-treated patients; the difference between the groups was significant (P =.0001). In nasal biopsy specimens, the number of eosinophil peroxidase-positive staining cells increased in the placebo-treated patients (P =.003) but not in the actively treated patients during the season; the difference between the groups was significant (P =.0001). The number of IgE(+) staining cells decreased significantly in the omalizumab group during the season in comparison with the placebo group (P =.04). CONCLUSION: The clinical benefit of treatment with omalizumab is associated with an anti-inflammatory effect on cellular markers in blood and nasal tissue. 相似文献
22.
Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome. 总被引:2,自引:0,他引:2
Leona Holmberg Kaoru Kikuchi Ted A Gooley Kristina M Adams David M Hockenbery Mary E D Flowers H Gary Schoch William Bensinger George B McDonald 《Biology of blood and marrow transplantation》2006,12(2):226-234
Graft-versus-host disease (GVHD) is seen in skin, intestinal mucosa, and liver after autologous stem cell transplantation. We reviewed 681 consecutive patients to estimate the probability of gastrointestinal (GI) GVHD, response to treatment, risk factors for development, and effect on survival. GI GVHD was defined by persistent symptoms, mucosal abnormalities at endoscopy, and histology showing apoptotic crypt cells with or without lymphoid infiltrates. The proportion of patients with GI GVHD was 90/681 (13%). Nausea and vomiting occurred in 90% and diarrhea in 40%. The mean time to developing symptoms was day +15, that to histologically proven diagnosis was day +42, and that to starting prednisone treatment was day +45 after stem cell infusion. Treatment with a short course of prednisone effected durable responses in 79% of patients, and an additional 18% responded to a second course of prednisone. A multivariable logistic regression model demonstrated that the combined factor of a diagnosis of breast cancer or hematologic malignancy and female sex was statistically significantly associated with the probability of GI GVHD (P = .003). Survival in patients with GI GVHD was not statistically different than that in those without GVHD. We conclude that women with breast cancer or hematologic malignancy are more likely to develop GI GVHD after autologous transplantation, and that treatment with prednisone was effective. 相似文献
23.
24.
25.
Holmberg SD Moorman AC Greenberg AE 《The New England journal of medicine》2004,350(7):730-2; author reply 730-2
26.
Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients 总被引:4,自引:0,他引:4
Lichtenstein KA Delaney KM Armon C Ward DJ Moorman AC Wood KC Holmberg SD;HIV Outpatient Study Investigators 《Journal of acquired immune deficiency syndromes (1999)》2003,32(1):48-56
To identify clinical factors associated with the incidence of HIV-1-associated lipoatrophy, HIV-1-infected patients in the HIV Outpatient Study (HOPS) were prospectively evaluated for clinical signs of lipoatrophy at two visits about 21 months apart. Development of lipoatrophy was analyzed in stratified and multivariate analyses for its relationship to immunologic, virologic, clinical, and drug treatment information for each patient. Of 337 patients with no lipoatrophy at Survey 1, 44 (13.1%) developed moderate or severe lipoatrophy between the two surveys. In multivariate analyses, significant risk factors for incident lipoatrophy were white race (OR = 5.2; 95% CI: 1.9-17.1; =.003), CD4 T-lymphocyte count at Survey 2 less than 100 cells/mm3 (OR = 4.2; 95% CI: 1.3-13.1; =.013), and body mass index (BMI) less than 24 kg/m2 (OR = 2.4; 95% CI: 1.1-5.4; =.024). Analyses that controlled for the severity of HIV illness demonstrated no significant association with use of or time on any antiretroviral agent or class of agents and the development of lipoatrophy. Some host factors and factors associated with previous or current severity of HIV infection, especially CD4 T-lymphocyte cell count, appeared to have the strongest association with incidence of lipoatrophy. 相似文献
27.
Human lymphocytes were cultured for two cell cycles in the presence of bromodeoxyuridine (BrdU), and the resulting metaphase chromosomes were first stained with quinacrine mustard (QM) and then, immediately afterwards, with Hoechst 33258, without any intermediate destaining. Both Q-banding patterns and sister chromatid differential staining were photographed subsequently on the same metaphase using two different filter blocks of the fluorescence microscope. 相似文献
28.
Establishment and Functional Implications of B-cell Connectivity 总被引:7,自引:0,他引:7
29.
Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers 总被引:16,自引:0,他引:16 下载免费PDF全文
Kuismanen SA Holmberg MT Salovaara R de la Chapelle A Peltomäki P 《The American journal of pathology》2000,156(5):1773-1779
Microsatellite instability (MSI) is a hallmark of hereditary nonpolyposis colorectal cancer, and in these patients, results from inherited defects in DNA mismatch repair genes, mostly MSH2 and MLH1. MSI also occurs in 15% of sporadic colorectal cancers, but in these tumors, its basis is less well characterized. We investigated 46 sporadic MSI+ colorectal cancers for changes in MSH2 and MLH1 protein expression, followed by the analysis of somatic mutation, loss of heterozygosity (LOH), and promoter hypermethylation as possible underlying defects. Most cases (36/46, 78%) showed lost or reduced MLH1 expression. Among these, a majority (83%) was associated with MLH1 promoter hypermethylation, whereas the rates of LOH and somatic mutation of MLH1 were 24% and 13%, respectively. Hypermethylation and LOH were inversely correlated, suggesting that they had alternative functions in the inactivation of MLH1. MSH2 expression was lost in 7/46 (15%), and of these, 2 (29%) showed LOH and/or somatic mutation of MSH2. We conclude that most sporadic MSI+ colorectal cancers have an MLH1-associated etiology and that epigenetic modification is a major mechanism of MLH1 inactivation. Moreover, we found a significantly lower prevalence for MLH1 promoter hypermethylation in hereditary nonpolyposis colorectal cancer tumors with MLH1 germline mutations (12/26, 46%), which might explain some differences that are known to occur in the clinicopathological characteristics and tumorigenic pathways between sporadic and hereditary MSI+ colorectal cancers. 相似文献
30.
Johannes Jrhult Jan Holmberg Jan Lundvall Stefan Mellander 《Acta physiologica (Oxford, England)》1976,97(4):470-475
Changes of the arterial plasma osmolality and of the glucose concentration were followed during a 30 min period of graded hemorrhagic hypotension (80, 50, and 30 mmHg) in the cat. Bleeding evoked a significant plasma hyperosmolality at all three hypotension levels and the responses were quantitatively related to the degree of hypotension. An approximate steady state increase in the arterial plasma osmolality was reached about 20 min after the start of the bleeding and it then averaged 8, 20, and 25 mOsm/kg H2O at 80, 50, and 30 mmHg, respectively. Bleeding also evoked an increase in the plasma glucose concentration, which almost entirely accounted for the observed hyperosmolality, especially at 80 and 50 mmHg. In late stages of hypotension at 30 mmHg, elevated plasma lactate and potassium concentrations contributed to the overall hyperosmolality. — Previous hemorrhagic hypotension experiments at 50 mmHg (Järhult 1975 b) have shown that hyperosmolality serves as an important regulator of the plasma and extracellular fluid volumes during bleeding. The present results indicate that such an osmolar compensatory mechanism is operating over wide ranges of hemorrhagic hypotension. 相似文献